Article
Unveiling the role of TLR9 promoter variants in susceptibility and clinical features of systemic lupus erythematosus.
Lupus - 1 Sept 2026
Soleimani Fatemeh, Karbalaei-Musa Hamidreza, Hajali Mohammad Hossein, Kenarangi Taiebe, Mosallaei Meysam, Ansari Narges
Abstract excerpt
ObjectiveSystemic lupus erythematosus (SLE) is a multifactorial autoimmune disease in which dysregulated nucleic acid sensing and type I interferon responses drive autoantibody production and organ damage. Toll-like receptor 9 (TLR9) regulates these pathways, and promoter variants (rs187084 and rs5743836) may alter TLR9 expression and modulate disease susceptibility and severity. This study evaluated the...
Topics
Join the communities discussing this publication.
